Barclays’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20
| Closed | -$2K | – | 4514 |
|
|
2025
Q1 | $2K | Hold |
20
| – | – | ﹤0.01% | 4279 |
|
|
2024
Q4 | $2K | Sell |
20
-1,153
| -98% | -$115K | ﹤0.01% | 4302 |
|
|
2024
Q3 | $112K | Sell |
1,173
-3,263
| -74% | -$312K | ﹤0.01% | 3712 |
|
|
2024
Q2 | $405K | Buy |
4,436
+605
| +16% | +$55.2K | ﹤0.01% | 2654 |
|
|
2024
Q1 | $348K | Sell |
3,831
-8,724
| -69% | -$792K | ﹤0.01% | 3035 |
|
|
2023
Q4 | $1.02M | Buy |
+12,555
| New | +$1.02M | ﹤0.01% | 2588 |
|
|
2021
Q4 | – | Sell |
-1,502
| Closed | -$109K | – | 3690 |
|
|
2021
Q3 | $109K | Sell |
1,502
-3,094
| -67% | -$225K | ﹤0.01% | 3194 |
|
|
2021
Q2 | $335K | Buy |
4,596
+4,496
| +4,496% | +$328K | ﹤0.01% | 2667 |
|
|
2021
Q1 | $7K | Hold |
100
| – | – | ﹤0.01% | 3741 |
|
|
2020
Q4 | $7K | Hold |
100
| – | – | ﹤0.01% | 3457 |
|
|
2020
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 3610 |
|
|
2020
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 3682 |
|
|
2020
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 3547 |
|
|
2019
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 3752 |
|
|
2019
Q3 | $6K | Buy |
+100
| New | +$6K | ﹤0.01% | 3939 |
|
|
2014
Q4 | – | Sell |
-250,000
| Closed | -$15.8M | – | 4281 |
|
|
2014
Q3 | $15.8M | Buy |
+250,000
| New | +$15.8M | 0.02% | 475 |
|